Business Description
J.Molner AS
ISIN : EE3100109034
Total Employee Number:
36Compare
Compare
Traded in other countries / regions
MOLNR.Estonia IPO Date
2022-11-10Description
J.Molner AS is an Estonia-based company engaged in research and development in the field of biotechnology. It is developing a portfolio of generic drug products for the United States and Canadian markets, consisting of both in-house developed medicines and acquired and in-licensed products. It operates through two complementary business units: internal generic drug development and specialized pharmaceutical services. It develops and commercializes sterile injectable, ophthalmic, and dermatology generic drugs, while also providing drug development services, analytical chemistry and stability testing. Its activities are divided into two business segments, Generic Drugs and Services, with Services generating maximum revenue. The Company generates maximum revenue from the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | 0.86 | |||||
Interest Coverage | 0.61 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.84 | |||||
Beneish M-Score | -1.32 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 79.6 | |||||
3-Year Book Growth Rate | 97 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.35 | |||||
9-Day RSI | 48.79 | |||||
14-Day RSI | 45.52 | |||||
3-1 Month Momentum % | -14.29 | |||||
6-1 Month Momentum % | -24.41 | |||||
12-1 Month Momentum % | -25.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.93 | |||||
Quick Ratio | 0.66 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 235.61 | |||||
Days Sales Outstanding | 57.01 | |||||
Days Payable | 422.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | 3.65 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 61.52 | |||||
Operating Margin % | 25.65 | |||||
Net Margin % | 11.17 | |||||
EBITDA Margin % | 75.74 | |||||
FCF Margin % | -223.82 | |||||
OCF Margin % | -131.68 | |||||
ROE % | 9.1 | |||||
ROA % | 2.61 | |||||
ROIC % | 6.64 | |||||
3-Year ROIIC % | 25.57 | |||||
ROC (Joel Greenblatt) % | 228.27 | |||||
ROCE % | 16.49 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 258.9 | |||||
PE Ratio without NRI | 258.9 | |||||
PS Ratio | 27.75 | |||||
PB Ratio | 15.07 | |||||
EV-to-EBIT | 53.02 | |||||
EV-to-EBITDA | 37.32 | |||||
EV-to-Revenue | 28.27 | |||||
EV-to-FCF | -12.63 | |||||
Price-to-GF-Value | 0.96 | |||||
Earnings Yield (Greenblatt) % | 1.89 | |||||
FCF Yield % | -8.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
J.Molner AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.146 | ||
| EPS (TTM) (€) | 0.073 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.55 | ||
| 3-Year Sortino Ratio | 1.17 | ||
| Volatility % | 31.98 | ||
| 14-Day RSI | 45.52 | ||
| 14-Day ATR (€) | 0.714021 | ||
| 20-Day SMA (€) | 19 | ||
| 12-1 Month Momentum % | -25.58 | ||
| 52-Week Range (€) | 10.2 - 30.8 | ||
| Shares Outstanding (Mil) | 1.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
J.Molner AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
J.Molner AS Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
J.Molner AS Frequently Asked Questions
What is J.Molner AS(OTSE:MOLNR)'s stock price today?
The current price of OTSE:MOLNR is €18.90. The 52 week high of OTSE:MOLNR is €30.80 and 52 week low is €10.20.
When is next earnings date of J.Molner AS(OTSE:MOLNR)?
The next earnings date of J.Molner AS(OTSE:MOLNR) is .
Does J.Molner AS(OTSE:MOLNR) pay dividends? If so, how much?
J.Molner AS(OTSE:MOLNR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on J.Molner AS
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers